Skip to content
Aperlena
Free alerts

TED - Tenders Electronic Daily (Publications Office of the EU) verified 6 hours ago Contract notice

Finland - Laboratory reagents - MLPA-Based CNV Testing for BRCA1/BRCA2

Open Finland Helsinki-Uusimaa Medical equipment & pharmaceuticals

Buyer HUS Group, the joint authority for Helsinki and Uusimaa

32 days left

Key facts

Closes
12:00 (UTC+2)
Procedure
Open procedure
  1. Published
  2. Today
  3. Deadline open for 33 days
  4. Awarded pending

Bidding window

32 days from publication to deadline

Usual length

Notices of this kind (Finland, open procedure, above the EU threshold) give a median of 31 days, half of them between 27 and 35 days, based on 7,466 notices of the last two years.

View the official notice Watch this tender
Add to calendar

If the deadline moves or the notice is corrected, we email you. Log in

Summary

Machine-generated summary

HUSLAB Laboratory of Genetics at HUS (Helsinki University Hospital) Diagnostic Center, an accredited genetic testing laboratory serving the Helsinki University Hospital area, is procuring an MLPA assay for detecting copy number variations in the BRCA1 and BRCA2 genes. The supply covers all reagents, controls, consumables, software, licences and components needed for routine use and reportable patient results, plus software, licences, user rights, technical support and related services for operation, data analysis and reporting. The initial contract period is two years, continuing indefinitely thereafter. Estimated consumption is about 1600 reportable patient samples per year; volumes are non-binding and purchases follow actual needs.

Description

HUSLAB Laboratory of Genetics at HUS (Helsinki University Hospital) Diagnostic Center is an SFS-EN ISO 15189:2022 accredited laboratory providing diagnostic and follow-up genetic testing services for patients within the Helsinki University Hospital area. The object of the procurement is an MLPA (Multiplex Ligation-dependent Probe Amplification) assay for the detection of copy number variations (CNVs) in BRCA1 and BRCA2 genes, including all reagents, controls, consumables, software, licences and other components required for routine use of the assay and generation of reportable patient results. The procurement also includes any software, licences, user rights, technical support and related services required for operation of the assay, data analysis and result reporting The contract period shall be two (2) years, after which the agreement shall continue for an indefinite period until terminated in accordance with the terms of the agreement. The estimated annual consumption is approximately 1600 reportable patient samples. The estimate is non-binding and provided for information purposes only. The contracting entity does not commit to any specific purchase volumes or quantities. Actual purchases will be made based on the contracting entity's needs and may be higher or lower than estimated.

Bid or no-bid?

Six questions before you commit a team. Under each one, what the register holds on it. The answers are yours.

  1. In your favour:

    Do we meet every eligibility criterion?

    Open procedure: any interested supplier may submit a bid.

    Above the EU threshold: open to companies from any EU country.

  2. Your call:

    Can we deliver this with the team we have?

    The register holds nothing on this. The official documents will.

  3. Your call:

    Do we have two comparable references?

    Comparable work is in Medical equipment & pharmaceuticals.

  4. In your favour:

    Is the deadline realistic for a proper offer?

    32 days left, 23 of them working days.

  5. Your call:

    Is there a margin at the likely winning price?

    In this country this kind of contract is usually awarded for between €250,000 and €1.4M.

  6. Your call:

    Do we know this buyer?

    The buyer has 10 notices in the register and no pattern of winners yet.

Can I bid?

  • Open procedure: any interested supplier may submit a bid. Above the EU threshold: open to companies from any EU country.
  • Certificates from another EU country? Check the equivalents on eCertis

Official source

Source: TED - Tenders Electronic Daily (Publications Office of the EU)

Always verify details on the official notice.

Report an error in this notice

Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 6 hours ago

View the official notice

What this market pays

The buyer has too few awards of its own in this sector, so this is the range of the last 609 awards for Medical equipment & pharmaceuticals in Finland.

Median award
€499,678
Middle half of past awards
€250,000 to €1.4M

TED - Tenders Electronic Daily (Publications Office of the EU) publishes no value for this notice, so it has no mark on the scale. The official documents may state one.

Award values as published by the official sources. Use them as a guide, not a rule: scope, lots and duration differ between contracts.

The buyer

Full buyer profile

HUS Group, the joint authority for Helsinki and Uusimaa

Finland

notices in the register
10
awards
2
awarded in total
€1.0M

This buyer has no award history in this sector yet. Usual winners, Medical equipment & pharmaceuticals - Finland

Company Wins Total awarded Last win
GE Healthcare Finland Oy 16 €11.1M Jun 2026
Medtronic Finland Oy 16 €8.2M Jul 2026
Respecta Oy 13 €4.8M Jun 2026
Siemens Healthcare Oy 12 €13.1M Aug 2026
Philips Oy 10 €5.9M Sep 2026

Based on 608 awards with a linked company profile over the last 2 years.

Market context

TED - Tenders Electronic Daily (Publications Office of the EU) publishes no value for this notice, so it cannot be placed among the open notices of its sector. The official documents may state one.

open now in Medical equipment & pharmaceuticals
11,052
median open notice
€143,235

Who wins in this market

Many suppliers

Finland · Medical equipment & pharmaceuticals

different companies won awards here
411
of the awards went to the three most frequent winners
7%
buyers awarded contracts here
161

Based on 608 awards with a named winner over the last 3 years. Counted by award, not by value, because lot and framework amounts are not comparable. Concentrated means the three most frequent winners took 65% or more of the awards; many suppliers, under 35% with at least ten different winners.

Competition

tenders per lot on average (open and restricted procedures)
3.0
of those lots received a single tender
17%
of the awards went to companies based in another country
8%
of the tenders came from another country
2%

As the official award notices state them, over the last 3 years. Tenders per lot count open and restricted procedures only: in a negotiated procedure or a direct award a single tender is the procedure itself. The country is the one the notice gives for the winner.

Similar tenders

Open now

7

days left

PET injectors

Finland Medical equipment & pharmaceuticals HUS-yhtymä

Awarded before

Never miss a tender like this

638 new notices in Medical equipment & pharmaceuticals in Finland in the last 7 days. Get an email when new ones appear. Free.

Set up my alert

32 days left

Open notice

Keyboard shortcuts

Read a list without reaching for the mouse. The shortcuts stay quiet while you type in a field.

j
Next result
k
Previous result
Enter
Open the result
n
Next page
p
Previous page
c
Compare this result
s
Shortlist this result
o
Open the result in a new tab
x
Set this result aside
/
Search from any page
Ctrl K
Search from any page
?
Show these shortcuts
Esc
Close

Start from a question

Browse by sector

Index

Close
Log in

Language